US at a glance
- Population
- 341.8 million 2025
- Life expectancy at birth
- 78.9 years, 2024
- People aged 65 and over
- 18.4 % of people, 2025
- Health spending per person
- 13,473 US$ per person, 2023
- Doctors
- 3.68 per 1,000 people, 2022
Updated
Reviewed by Chandani Patel
US Vaginal Health Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Condition, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$734.2 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.72 Bn | — | — |
| 2025 (base) | $1.79 Bn | +$67.1 Mn | — |
| 2026 (forecast) | $1.86 Bn | +$69.7 Mn | +3.9% |
| 2027 (forecast) | $1.93 Bn | +$72.4 Mn | +8% |
| 2028 (forecast) | $2.00 Bn | +$75.2 Mn | +12.2% |
| 2029 (forecast) | $2.08 Bn | +$78.1 Mn | +16.5% |
| 2030 (forecast) | $2.16 Bn | +$81.2 Mn | +21.1% |
| 2031 (forecast) | $2.25 Bn | +$84.4 Mn | +25.8% |
| 2032 (forecast) | $2.33 Bn | +$87.6 Mn | +30.7% |
| 2033 (forecast) | $2.43 Bn | +$91.1 Mn | +35.8% |
| 2034 (forecast) | $2.52 Bn | +$94.6 Mn | +41.1% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.79 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $2.52 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 3.9% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, condition and distribution channel (see all) |
| Key players | Bayer AG, Church & Dwight Co., Inc, Reckitt Benckiser Group PLC, Procter & Gamble, Combe (see all) |
| Regulator in the US | FDASource: US Food and Drug Administration. Checked 14 Nov 2026.Source: US Food and Drug Administration. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Vaginal health products include probiotics, washes, moisturisers and treatments for infections and dryness.
Key segments of the vaginal Health Products market include product (Probiotics, Moisturizers and Lubricants and Antifungal Treatments) and condition (Bacterial Vaginosis, Yeast Infections and Dryness).
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the vaginal Health Products market. New products designed around women's biology and digital care are improving access.
Femtech, personalised care and new treatments for under-served conditions open strong growth for the vaginal Health Products market, especially as employers and payers add women's health benefits.
Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the vaginal Health Products market.
The vaginal Health Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
New drugs need approval from the US Food and Drug Administration (FDA); many over-the-counter medicines are sold under FDA monographs instead.[1] Dietary supplements do not need FDA approval before sale; under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the FDA acts against unsafe or mislabelled products.[2]
[1] US Food and Drug Administration. Checked 14 Nov 2026.
[2] US Food and Drug Administration. Checked 14 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern vaginal Health Products products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in the US.
What doctors and scientists are doing in Vaginal Health Products right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.
From our blog
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
Pharmaceuticals · US
Healthcare Services · US
Pharmaceuticals · US
Medical Devices · US
Pharmaceuticals · US
Pharmaceuticals · US